Thyroid Disease Testing
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Illinois Policy CPCPLAB019 alerts
Get alerted when Policy CPCPLAB019 changes without checking for updates manually.
Monitor payer policy activity
Defines reimbursement and lab management criteria for thyroid function and antibody testing for Blue Cross Blue Shield of Illinois members; applies to providers submitting claims to BCBSIL products and affects ordering and billing for thyroid-related laboratory services.
New policy.
Coverage and Medical Necessity Criteria
Medically necessary/reimbursable testing
Covered when the specific clinical scenarios and monitoring intervals below are met
See Note 1 for symptom list
See Note 2 for symptom list
See Note 3 regarding trimester-specific ranges
See Note 3
Testing for thyrotropin-releasing hormone (TRH) or thyroxine-binding globulin (TBG) to evaluate the cause of hyperthyroidism or hypothyroidism is not reimbursable. This exclusion applies specifically to TRH and TBG when ordered for diagnostic evaluation of thyroid dysfunction and is stated alongside other testing limitations in the policy.
For asymptomatic nonpregnant individuals, thyroid testing performed as part of a general examination when there are no abnormal findings is not reimbursable. Orders for thyroid function tests in this scenario should be supported by documented signs, symptoms, or risk factors to be considered for reimbursement.
No additional explicit exclusions are provided in the referenced policy update history or surrounding chunks beyond those already listed in the reimbursement information. The policy update notes the policy is newly established effective 01/01/2026.
Measurement of total T3 (TT3) and/or free T3 (fT3) to assess hypothyroidism or to guide levothyroxine dosing is specified as not reimbursable. The policy also states that testing of reverse T3, T3 uptake, and total T4 is not reimbursable in situations not mentioned as covered.
No explicit additional statements labeled 'not medically necessary' are contained in the cited policy update history chunk. The primary not-reimbursable and exclusion language for TT3/fT3 and related tests is captured in the reimbursement information.
Procedure and Billing Codes
Provider Responsibilities and Operational Notes
Provider documentation responsibility — submit accurate documentation and additional records upon request
The Plan has implemented certain lab management reimbursement criteria. Not all requirements apply to each product. Providers are urged to review Plan documents for eligible coverage for services rendered. If a conflict arises between this Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern. If a conflict arises between this CPCP and any provider contract pursuant to which a provider participates in and/or provides Covered Services to eligible member(s) and/or plans, the provider contract will govern. 'Plan documents' include, but are not limited to, Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents. Blue Cross and Blue Shield of Illinois may use reasonable discretion interpreting and applying this policy to services being delivered in a particular case. BCBSIL has full and final discretionary authority for their interpretation and application to the extent provided under any applicable plan documents. Providers are responsible for submission of accurate documentation of services performed. Providers are expected to submit claims for services rendered using valid code combinations from HIPAA-approved code sets and to code appropriately according to industry standard coding guidelines (including, but not limited to, Uniform Billing Editor, AMA CPT, CPT Assistant, HCPCS, ICD-10 CM/PCS, NDCs, DRG guidelines, CMS NCCI Policy Manual and CCI table edits). Claims are subject to code edit protocols and claim review, including review against terms of benefit coverage, provider contract language, medical policies, clinical payment and coding policies, and coding software logic. Upon request, the provider must submit any additional documentation.
- Not all requirements apply to each product; review plan documents for eligible coverage
- Claims subject to code edits, benefit terms, provider contracts, medical policies, and coding software logic
- Providers must submit accurate documentation and provide additional records upon request
Product-specific reimbursement eligibility — providers should review plan documents for eligible coverage
The Plan has implemented certain lab management reimbursement criteria. Not all requirements apply to each product. Providers are urged to review Plan documents for eligible coverage for services rendered.
- Product-specific reimbursement eligibility — providers should review plan documents for eligible coverage
References listed to support clinical guidance
References listed support the clinical guidance and utilization expectations in this policy. Providers may consult these sources when preparing documentation or clinical rationale for services rendered.
Step therapy
No step therapy requirements are specified in this policy.
- No step therapy requirements mentioned
Claims subject to review
Claims and services are subject to review per plan documents, provider contracts, medical policies, clinical payment and coding policies, and code-edit protocols. Providers should reference the applicable plan documents and contracts for coverage determinations.
- Claims subject to review — subject to plan documents, contracts, policies, coding edits
Prior authorization / Policy effective date
This policy became effective 01/01/2026 as a new policy (Policy Update History: 09/05/2025; Summary of Changes = 01/01/2026: New policy). No prior authorization requirements are specified within this section; providers should review product-specific plan documents for any prior authorization rules that may apply.
- Policy effective 01/01/2026 — New policy
- No prior authorization specified in this section; review plan documents for product-specific rules
Clinical Background and Rationale
Thyroid function testing—principally TSH, free T4 (fT4), and when indicated total or free T3—is used to diagnose and monitor hypothyroidism and hyperthyroidism. The policy emphasizes appropriate use and monitoring intervals for symptomatic individuals and special populations, and it also clarifies tests that are not reimbursable (for example, TRH, TBG, reverse T3, T3 uptake, TT3/fT3 for dose assessment). The policy was instituted as a new policy effective 01/01/2026.
Test and Biomarker Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.